115 related articles for article (PubMed ID: 37839003)
1. [Epidemiological and clinicopathological characteristics of prostate cancer in Hunan].
Zou B; Long Y; Yang ZM; Gao RS; Lin QF; Dai XJ; Yi G; Wang QZ; Zhou Q; Zhang XB
Zhonghua Nan Ke Xue; 2022 Sep; 28(9):786-791. PubMed ID: 37839003
[TBL] [Abstract][Full Text] [Related]
2. [Clinicopathologic characteristics and prognosis of early onset prostate cancer].
Wang Y; Du SJ; Zhang JX; He HY
Zhonghua Bing Li Xue Za Zhi; 2017 Jun; 46(6):373-377. PubMed ID: 28591982
[No Abstract] [Full Text] [Related]
3. Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between "precursor-like" and "regular type" lesions.
Miyai K; Divatia MK; Shen SS; Miles BJ; Ayala AG; Ro JY
Int J Clin Exp Pathol; 2014; 7(5):2518-26. PubMed ID: 24966964
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of adverse pathology features in grade group 2 prostatectomy specimens with syn- or metachronous metastatic disease.
Ma C; Downes M; Jain R; Ientilucci M; Fleshner N; Perlis N; van der Kwast T
Prostate; 2022 Feb; 82(3):345-351. PubMed ID: 34878188
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Accuracy of Prostate Biopsy for Detecting Cribriform Gleason Pattern 4 Carcinoma and Intraductal Carcinoma in Paired Radical Prostatectomy Specimens: Implications for Active Surveillance.
Ericson KJ; Wu SS; Lundy SD; Thomas LJ; Klein EA; McKenney JK
J Urol; 2020 Feb; 203(2):311-319. PubMed ID: 31483693
[TBL] [Abstract][Full Text] [Related]
6. Intraductal carcinoma of the prostate in prostate biopsy samples: correlation with aggressive pathological features after radical prostatectomy and prognostic value in high-risk prostate cancer.
Zhu S; Zhao JG; Chen JR; Liu ZH; Sun GX; Wang ZP; Ni YC; Dai JD; Shen PF; Zeng H
Asian J Androl; 2020; 22(5):519-525. PubMed ID: 31710002
[TBL] [Abstract][Full Text] [Related]
7. Associations of Prostate-Specific Antigen, Prostate Carcinoma Tissue Gleason Score, and Androgen Receptor Expression with Bone Metastasis in Patients with Prostate Carcinoma.
Chen Y; Lin Y; Nie P; Jiang W; Liu Y; Yuan R; Li M; Zhao S; Lin H; Li P; Zhang J; Hu Z; Xu J; Zhu X
Med Sci Monit; 2017 Apr; 23():1768-1774. PubMed ID: 28400549
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy.
Koie T; Mitsuzuka K; Yoneyama T; Narita S; Kawamura S; Kaiho Y; Tsuchiya N; Tochigi T; Habuchi T; Arai Y; Ohyama C; Yoneyama T; Tobisawa Y
Int J Clin Oncol; 2015 Feb; 20(1):176-81. PubMed ID: 24771079
[TBL] [Abstract][Full Text] [Related]
9. Trend of Adverse Stage Migration in Patients Treated with Radical Prostatectomy for Localized Prostate Cancer.
Preisser F; Marchioni M; Nazzani S; Bandini M; Tian Z; Saad F; Pompe RS; Briganti A; Budäus L; Montorsi F; Huland H; Graefen M; Tilki D; Karakiewicz PI
Eur Urol Oncol; 2018 Jun; 1(2):160-168. PubMed ID: 31100241
[TBL] [Abstract][Full Text] [Related]
10. [Microfocal prostate cancer: a clinicopathological analysis of 206 cases].
Nie L; Chen XQ; Song YK; Zhang MN; Xu M; Gong J; Zhou Q; Chen N
Zhonghua Bing Li Xue Za Zhi; 2022 Jul; 51(7):634-639. PubMed ID: 35785834
[No Abstract] [Full Text] [Related]
11. The expression profile and heterogeneity analysis of ERG in 633 consecutive prostate cancers from a single center.
Nie L; Pan X; Zhang M; Yin X; Gong J; Chen X; Xu M; Zhou Q; Chen N
Prostate; 2019 Jun; 79(8):819-825. PubMed ID: 30900303
[TBL] [Abstract][Full Text] [Related]
12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
13. The increase of stage, grading, and metastases in patients undergoing radical prostatectomy during the last decade.
Beck V; Schlenker B; Herlemann A; Apfelbeck M; Buchner A; Gratzke C; Stief CG; Tritschler S
World J Urol; 2019 Jun; 37(6):1103-1109. PubMed ID: 30225798
[TBL] [Abstract][Full Text] [Related]
14. The influence of the presence of intraductal carcinoma of the prostate on the grade group system's prognostic performance.
Kato M; Hirakawa A; Kobayashi Y; Yamamoto A; Ishida R; Sano T; Kimura T; Majima T; Ishida S; Funahashi Y; Sassa N; Fujita T; Matsukawa Y; Yamamoto T; Hattori R; Gotoh M; Tsuzuki T
Prostate; 2019 Jul; 79(10):1065-1070. PubMed ID: 31025722
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel non-invasive biological marker to overcome the shortcomings of PSA in diagnosis and risk stratification for prostate cancer: Initial prospective study of developmental endothelial locus-1 protein.
Chung JW; Kim HT; Ha YS; Lee EH; Chun SY; Lee CH; Byeon KH; Choi SH; Lee JN; Kim BS; Kim TH; Yoo ES; Yoon GS; Baek MC; Kwon TG
PLoS One; 2021; 16(4):e0250254. PubMed ID: 33901217
[TBL] [Abstract][Full Text] [Related]
16. Intraductal carcinoma of the prostate (IDC-P) lowers apparent diffusion coefficient (ADC) values among intermediate risk prostate cancers.
Currin S; Flood TA; Krishna S; Ansari A; McInnes MDF; Schieda N
J Magn Reson Imaging; 2019 Jul; 50(1):279-287. PubMed ID: 30585372
[TBL] [Abstract][Full Text] [Related]
17. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.
Keefe DT; Schieda N; El Hallani S; Breau RH; Morash C; Robertson SJ; Mai KT; Belanger EC; Flood TA
Virchows Arch; 2015 Oct; 467(4):437-42. PubMed ID: 26229020
[TBL] [Abstract][Full Text] [Related]
18. Risk of Pathologic Upgrading or Locally Advanced Disease in Early Prostate Cancer Patients Based on Biopsy Gleason Score and PSA: A Population-Based Study of Modern Patients.
Caster JM; Falchook AD; Hendrix LH; Chen RC
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):244-51. PubMed ID: 25841621
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and molecular characteristics of prostate cancer diagnosed in young men aged up to 45 years.
Baniak N; Sholl LM; Mata DA; D'Amico AV; Hirsch MS; Acosta AM
Histopathology; 2021 May; 78(6):857-870. PubMed ID: 33306242
[TBL] [Abstract][Full Text] [Related]
20. Association between PSA density and pathologically significant prostate cancer: The impact of prostate volume.
Omri N; Kamil M; Alexander K; Alexander K; Edmond S; Ariel Z; David K; Gilad AE; Azik H
Prostate; 2020 Dec; 80(16):1444-1449. PubMed ID: 32970856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
